Untitled

Untitled

“…Oxytocin seems to have the potential to considerably reduce the amount of energy required to ablate uterine fibroids, as well as reduce treatment duration and increase treatment efficiency [7][8][9]. Uterine fibroids are the most common benign tumor in women of reproductive age, occurring in 20-44% of women and in 0.5-6% of pregnant women [10][11][12]. In recent years, there has been a trend towards an increase in the incidence of uterine fibroids and rejuvenation of the disease [13,14].…”